Our portfolio of companies

Discover the companies that we’ve helped to create from Oxford University knowledge and research

Explore our portfolio

Our portfolio is made up of a diverse range of companies born from the University of Oxford’s world-leading knowledge and research.

Whether it’s a spinout company bringing intellectual property to market, or a startup founded through our Incubator, each one has been enabled by our expertise. Together they represent one of the most diverse and dynamic university innovation ecosystems in the world.

We play a central role in bringing companies to life, and we also manage the University’s shareholdings in the companies on its behalf.

2024

Yellowstone Biosciences

Commercialising T cell receptor-based immunotherapy for multiple indications.

Incorporated: March 2024

Origin: Oxford University, Radcliffe Department of Medicine (RDM)

Sector: Life Sciences

https://yellowstonebio.com/

FlexSR

A new approach to automatic speech recognition technology.

Incorporated: February 2024

Origin: Oxford University

Sector: Software & AI

https://flexsr.app/

2023

MatchBio

MatchBio's technology can improve the function of antigen receptors, for example by tuning their antigen sensitivity of their existing products.

Incorporated: August 2023

Origin: Oxford University, Sir William Dunn School of Pathology

Sector: Life Sciences

https://www.matchbiotx.com/

SnowFox Discovery

Aims to identify and explore natural hydrogen sources.

Incorporated: July 2023

Origin: Oxford University, Earth Sciences

Sector: Climate & Sustainability

https://www.snowfoxdiscovery.com/

Veer Technologies

All-in-one recruitment platform with video capacity.

Incorporated: July 2023

Origin: Oxford University, Department of Computer Science

Sector: Software & AI

https://teamveer.com/

AlveoGene

The advancement, through pre-clinical and clinical trials, the development a number of lentiviral-based gene therapies for respiratory diseases.

Incorporated: July 2023

Origin: University of Oxford, Nuffield Department of Clinical Laboratory Sciences

Sector: Life Sciences

https://alveogene.com/

Glox Therapeutics

The company is focused on the use of bacteriocins and anti-microbial therapies.

Incorporated: April 2023

Origin: Oxford University, Biochemistry

Sector: Life Sciences

https://gloxtherapeutics.com/

Isogenix

Company developing a new gene therapy products for the treatment of rare diseases.

Incorporated: April 2023

Origin: Oxford University, Paediatrics

Sector: Life Sciences

https://isogenixtx.com/

Beacon Therapeutics

Clinical-stage biotechnology company dedicated to saving and restoring sight for people living with rare and prevalent ocular diseases, harnessing the transformative power of gene therapy.

Incorporated: March 2023

Origin: Oxford University, Nuffield Department of Clinical Neurosciences

Sector: Life Sciences

https://www.beacontx.com/